{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:05:40Z","timestamp":1791201940319,"version":"4.2.0"},"reference-count":79,"publisher":"Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>The impact of dermatological diseases goes beyond symptoms and often includes psychosocial burden. Self-stigmatization plays a key role in this relationship and was compared in patients with psoriasis and atopic dermatitis to evaluate the validity of cross-disease stigmatization models. In total, 101 patients per indication were included in this cross-sectional study. Besides sociodemographic and clinical data, patient-reported outcome measures relating to self-stigmatization, depression, anxiety, and quality of life were compared across groups. Sociodemographic and clinical factors were tested for their moderating effects between self-stigmatization and quality of life. Group mean comparisons yielded no significant differences in self-stigmatization between patient groups. In both diseases, self-stigmatization significantly predicted depression and anxiety symptoms as well as quality of life. Current symptoms, not having close social relationships, and lower age predicted self-stigma in patients with psoriasis, whereas the involvement of sensitive body areas, the sum of previous treatments, and female sex were predictors in patients with atopic dermatitis. In both groups, symptoms had significantly moderating effects. The results underline the relevance of self-stigmatization in patients with chronic skin diseases. Awareness should be raised, screening implemented, and psychosocial support offered early on. Assessments, conceptual models of self-stigma, and interventions are probably applicable for both diseases.<\/jats:p>","DOI":"10.2340\/actadv.v103.3962","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T12:54:52Z","timestamp":1680612892000},"page":"adv3962","source":"Crossref","is-referenced-by-count":19,"title":["A Comparative Analysis of the Predictors, Extent and Impacts of Self-stigma in Patients with Psoriasis and Atopic Dermatitis"],"prefix":"10.2340","volume":"103","author":[{"given":"Sophie","family":"Schlachter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tsianakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"30371","doi-asserted-by":"crossref","unstructured":"Mah\u00e9 E. Childhood psoriasis. Eur J Dermatol 2016; 26: 537-548.","DOI":"10.1684\/ejd.2016.2932"},{"key":"30372","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1684\/ejd.2016.2932","DOI":"10.1684\/ejd.2016.2932"},{"key":"30373","doi-asserted-by":"crossref","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. Bmj 2020; 369: m1590.","DOI":"10.1136\/bmj.m1590"},{"key":"30374","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmj.m1590","DOI":"10.1136\/bmj.m1590"},{"key":"30375","doi-asserted-by":"crossref","unstructured":"Bylund S, Kobyletzki LB, Svalstedt M, Svensson \u00c5. Prevalence and Incidence of Atopic Dermatitis: A Systematic Review. Acta Derm Venereol 2020; 100: adv00160.","DOI":"10.2340\/00015555-3510"},{"key":"30376","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/00015555-3510","DOI":"10.2340\/00015555-3510"},{"key":"30377","doi-asserted-by":"crossref","unstructured":"Sommer R, Topp J, Mrowietz U, Zander N, Augustin M. Perception and determinants of stigmatization of people with psoriasis in the German population. J Eur Acad Dermatol Venereol 2020; 34: 2846-2855.","DOI":"10.1111\/jdv.16436"},{"key":"30378","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.16436","DOI":"10.1111\/jdv.16436"},{"key":"30379","doi-asserted-by":"crossref","unstructured":"Chernyshov PV. Stigmatization and self-perception in children with atopic dermatitis. Clin Cosmet Investig Dermatol 2016; 9: 159-166.","DOI":"10.2147\/CCID.S91263"},{"key":"30380","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2147\/CCID.S91263","DOI":"10.2147\/CCID.S91263"},{"key":"30381","doi-asserted-by":"crossref","unstructured":"Sahi FM, Masood A, Danawar NA, Mekaiel A, Malik BH. Association Between Psoriasis and Depression: A Traditional Review. Cureus 2020; 12: e9708.","DOI":"10.7759\/cureus.9708"},{"key":"30382","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.7759\/cureus.9708","DOI":"10.7759\/cureus.9708"},{"key":"30383","doi-asserted-by":"crossref","unstructured":"Wittkowski A, Richards HL. How beneficial is cognitive behaviour therapy in the treatment of atopic dermatitis? A single-case study. Psychol Health Med 2007; 12: 445-449.","DOI":"10.1080\/13548500601109268"},{"key":"30384","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/13548500601109268","DOI":"10.1080\/13548500601109268"},{"key":"30385","doi-asserted-by":"crossref","unstructured":"Augustin M. Cumulative life course impairment: identifying patients at risk. Curr Probl Dermatol 2013; 44: 74-81.","DOI":"10.1159\/000350555"},{"key":"30386","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1159\/000350555","DOI":"10.1159\/000350555"},{"key":"30387","unstructured":"World Health Organization (WHO). Resolutions and Decisions. Sixty-Seventh World Health Assembly. Geneva, 2014."},{"key":"30388","doi-asserted-by":"crossref","unstructured":"Sommer R, Augustin M, Mrowietz U, Topp J, Sch\u00e4fer I, von Spreckelsen R. Stigmatisierungserleben bei Psoriasis - qualitative Analyse aus Sicht von Betroffenen, Angeh\u00f6rigen und Versorgern. Hautarzt 2019; 70: 520-526.","DOI":"10.1007\/s00105-019-4411-y"},{"key":"30389","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00105-019-4411-y","DOI":"10.1007\/s00105-019-4411-y"},{"key":"30390","doi-asserted-by":"crossref","unstructured":"Link BG, Phelan JC. Conceptualizing stigma. Annual Review of Sociology 2001; 27: 363-385.","DOI":"10.1146\/annurev.soc.27.1.363"},{"key":"30391","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1146\/annurev.soc.27.1.363","DOI":"10.1146\/annurev.soc.27.1.363"},{"key":"30392","doi-asserted-by":"crossref","unstructured":"Corrigan PW, Watson AC. The paradox of self-stigma and mental illness. Clinical Psychology: Science and Practice 2002; 9: 35-53.","DOI":"10.1093\/clipsy.9.1.35"},{"key":"30393","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/clipsy.9.1.35","DOI":"10.1093\/clipsy.9.1.35"},{"key":"30394","doi-asserted-by":"crossref","unstructured":"Bos AER, Pryor JB, Reeder GD, Stutterheim SE. Stigma: advances in theory and research. Basic and Applied Social Psychology 2013; 35: 1-9.","DOI":"10.1080\/01973533.2012.746147"},{"key":"30395","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/01973533.2012.746147","DOI":"10.1080\/01973533.2012.746147"},{"key":"30396","doi-asserted-by":"crossref","unstructured":"Luck-Sikorski C, Ro\u00dfmann P, Topp J, Augustin M, Sommer R, Weinberger NA. Assessment of stigma related to visible skin diseases: a systematic review and evaluation of patient-reported outcome measures. J Eur Acad Dermatol Venereol 2022; 36: 499-525.","DOI":"10.1111\/jdv.17833"},{"key":"30397","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.17833","DOI":"10.1111\/jdv.17833"},{"key":"30398","doi-asserted-by":"crossref","unstructured":"Germain N, Augustin M, Fran\u00e7ois C, Legau K, Bogoeva N, Desroches M, et al. Stigma in visible skin diseases - a literature review and development of a conceptual model. J Eur Acad Dermatol Venereol 2021; 35: 1493-1504.","DOI":"10.1111\/jdv.17110"},{"key":"30399","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.17110","DOI":"10.1111\/jdv.17110"},{"key":"30400","doi-asserted-by":"crossref","unstructured":"Topp J, Andrees V, Weinberger NA, Sch\u00e4fer I, Sommer R, Mrowietz U, et al. Strategies to reduce stigma related to visible chronic skin diseases: a systematic review. J Eur Acad Dermatol Venereol 2019; 33: 2029-2038.","DOI":"10.1111\/jdv.15734"},{"key":"30401","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.15734","DOI":"10.1111\/jdv.15734"},{"key":"30402","doi-asserted-by":"crossref","unstructured":"Halioua B, Bastien M, Taieb C, Thenie C, Veniard C, Noel M, et al. Prevalence and predictors of perceived stigmatization in adult patients with moderate-to-severe atopic dermatitis in France. J Eur Acad Dermatol Venereol 2023; 37: e80-e81.","DOI":"10.1111\/jdv.18515"},{"key":"30403","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.18515","DOI":"10.1111\/jdv.18515"},{"key":"30404","doi-asserted-by":"crossref","unstructured":"Schmid-Ott G, Burchard R, Niederauer HH, Lamprecht F, K\u00fcnsebeck HW. Stigmatisierungsgef\u00fchl und Lebensqualit\u00e4t bei Patienten mit Psoriasis und Neurodermitis. Hautarzt 2003; 54: 852-857.","DOI":"10.1007\/s00105-003-0539-9"},{"key":"30405","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00105-003-0539-9","DOI":"10.1007\/s00105-003-0539-9"},{"key":"30406","doi-asserted-by":"crossref","unstructured":"Schmid-Ott G, Kuensebeck HW, Jaeger B, Werfel T, Frahm K, Ruitman J, et al. Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol 1999; 79: 443-447.","DOI":"10.1080\/000155599750009870"},{"key":"30407","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/000155599750009870","DOI":"10.1080\/000155599750009870"},{"key":"30408","doi-asserted-by":"crossref","unstructured":"Kowalewska B, Cybulski M, Jankowiak B, Krajewska-Ku\u0142ak E. Acceptance of illness, satisfaction with life, sense of stigmatization, and quality of life among people with psoriasis: a cross-sectional study. Dermatol Ther (Heidelb) 2020; 10: 413-430.","DOI":"10.1007\/s13555-020-00368-w"},{"key":"30409","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s13555-020-00368-w","DOI":"10.1007\/s13555-020-00368-w"},{"key":"30410","doi-asserted-by":"crossref","unstructured":"van Beugen S, van Middendorp H, Ferwerda M, Smit JV, Zeeuwen-Franssen ME, Kroft EB, et al. Predictors of perceived stigmatization in patients with psoriasis. Br J Dermatol 2017; 176: 687-694.","DOI":"10.1111\/bjd.14875"},{"key":"30411","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.14875","DOI":"10.1111\/bjd.14875"},{"key":"30412","doi-asserted-by":"crossref","unstructured":"Hawro M, Maurer M, Weller K, Maleszka R, Zalewska-Janowska A, Kaszuba A, et al. Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis. J Am Acad Dermatol 2017; 76: 648-654.e2.","DOI":"10.1016\/j.jaad.2016.10.040"},{"key":"30413","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2016.10.040","DOI":"10.1016\/j.jaad.2016.10.040"},{"key":"30414","doi-asserted-by":"crossref","unstructured":"Lu Y, Duller P, van der Valk PGM, Evers AWM. Helplessness as Predictor of Perceived Stigmatization in Patients with Psoriasis and Atopic Dermatitis. Dermatology and Psychosomatics \/ Dermatologie und Psychosomatik 2003; 4: 146-150.","DOI":"10.1159\/000073991"},{"key":"30415","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1159\/000073991","DOI":"10.1159\/000073991"},{"key":"30416","doi-asserted-by":"crossref","unstructured":"Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53-63.","DOI":"10.1016\/S0190-9622(89)70007-4"},{"key":"30417","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0190-9622(89)70007-4","DOI":"10.1016\/S0190-9622(89)70007-4"},{"key":"30418","doi-asserted-by":"crossref","unstructured":"Jankowiak B, Kowalewska B, Krajewska-Ku\u0142ak E, Kowalczuk K, Khvorik DF. The sense of stigmatization in patients with plaque psoriasis. Dermatology 2021; 237: 611-617.","DOI":"10.1159\/000510654"},{"key":"30419","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1159\/000510654","DOI":"10.1159\/000510654"},{"key":"30420","doi-asserted-by":"crossref","unstructured":"Kowalewska B, Jankowiak B, Cybulski M, Krajewska-Ku\u0142ak E, Khvorik DF. Effect of disease severity on the quality of life and sense of stigmatization in psoriatics. Clin Cosmet Investig Dermatol 2021; 14: 107-121.","DOI":"10.2147\/CCID.S286312"},{"key":"30421","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2147\/CCID.S286312","DOI":"10.2147\/CCID.S286312"},{"key":"30422","doi-asserted-by":"crossref","unstructured":"\u0141akuta P, Marcinkiewicz K, Bergler-Czop B, Brzezi\u0144ska-Wcis\u0142o L, S\u0142omian A. Associations between site of skin lesions and depression, social anxiety, body-related emotions and feelings of stigmatization in psoriasis patients. Postepy Dermatol Alergol 2018; 35: 60-66.","DOI":"10.5114\/pdia.2016.62287"},{"key":"30423","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.5114\/pdia.2016.62287","DOI":"10.5114\/pdia.2016.62287"},{"key":"30424","doi-asserted-by":"crossref","unstructured":"Dimitrov D, Matusiak \u0141, Szepietowski JC. Stigmatization in Arabic psoriatic patients in the United Arab Emirates - a cross sectional study. Postepy Dermatol Alergol 2019; 36: 425-430.","DOI":"10.5114\/ada.2018.80271"},{"key":"30425","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.5114\/ada.2018.80271","DOI":"10.5114\/ada.2018.80271"},{"key":"30426","doi-asserted-by":"crossref","unstructured":"Sommer R, Augustin M, Hilbring C, St\u00e4nder S, Hubo M, Hutt HJ, et al. Significance of chronic pruritus for intrapersonal burden and interpersonal experiences of stigmatization and sexuality in patients with psoriasis. J Eur Acad Dermatol Venereol 2021; 35: 1553-1561.","DOI":"10.1111\/jdv.17188"},{"key":"30427","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.17188","DOI":"10.1111\/jdv.17188"},{"key":"30428","doi-asserted-by":"crossref","unstructured":"Augustin M, Sommer R, Kirsten N, Danckworth A, Radtke MA, Reich K, et al. Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients. Br J Dermatol 2019; 181: 358-365.","DOI":"10.1111\/bjd.17403"},{"key":"30429","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.17403","DOI":"10.1111\/bjd.17403"},{"key":"30430","doi-asserted-by":"crossref","unstructured":"L\u00f6we B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 2010; 122: 86-95.","DOI":"10.1016\/j.jad.2009.06.019"},{"key":"30431","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jad.2009.06.019","DOI":"10.1016\/j.jad.2009.06.019"},{"key":"30432","doi-asserted-by":"crossref","unstructured":"Kroenke K, Spitzer RL, Williams JB, Monahan PO, L\u00f6we B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007; 146: 317-325.","DOI":"10.7326\/0003-4819-146-5-200703060-00004"},{"key":"30433","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.7326\/0003-4819-146-5-200703060-00004","DOI":"10.7326\/0003-4819-146-5-200703060-00004"},{"key":"30434","doi-asserted-by":"crossref","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"30435","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01167.x","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"30436","doi-asserted-by":"crossref","unstructured":"Cappelleri JC, Bushmakin AG, Harness J, Mamolo C. Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity. Qual Life Res 2013; 22: 2489-2499.","DOI":"10.1007\/s11136-013-0384-y"},{"key":"30437","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s11136-013-0384-y","DOI":"10.1007\/s11136-013-0384-y"},{"key":"30438","doi-asserted-by":"crossref","unstructured":"Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011; 303: 1-10.","DOI":"10.1007\/s00403-010-1080-1"},{"key":"30439","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00403-010-1080-1","DOI":"10.1007\/s00403-010-1080-1"},{"key":"30440","doi-asserted-by":"crossref","unstructured":"Leshem YA, Hajar T, Hanifin JM, Simpson EL. What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study. Br J Dermatol 2015; 172: 1353-1357.","DOI":"10.1111\/bjd.13662"},{"key":"30441","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.13662","DOI":"10.1111\/bjd.13662"},{"key":"30442","doi-asserted-by":"crossref","unstructured":"Zi\u0119ciak T, Rzepa T, Kr\u00f3l J, \u017baba R. Stigmatization feelings and depression symptoms in psoriasis patients. Psychiatr Pol 2017; 51: 1153-1163.","DOI":"10.12740\/PP\/68848"},{"key":"30443","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.12740\/PP\/68848","DOI":"10.12740\/PP\/68848"},{"key":"30444","doi-asserted-by":"crossref","unstructured":"Ellemers N. Gender Stereotypes. Annu Rev Psychol 2018; 69: 275-298.","DOI":"10.1146\/annurev-psych-122216-011719"},{"key":"30445","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1146\/annurev-psych-122216-011719","DOI":"10.1146\/annurev-psych-122216-011719"},{"key":"30446","doi-asserted-by":"crossref","unstructured":"Schienle A, Wabnegger A. Self-disgust in patients with dermatological diseases. Int J Behav Med 2022; 29: 827-832.","DOI":"10.1007\/s12529-022-10058-w"},{"key":"30447","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s12529-022-10058-w","DOI":"10.1007\/s12529-022-10058-w"},{"key":"30448","doi-asserted-by":"crossref","unstructured":"Fabrazzo M, Cipolla S, Signoriello S, Camerlengo A, Calabrese G, Giordano GM, et al. A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa. Eur Psychiatry 2021; 64: e71.","DOI":"10.1192\/j.eurpsy.2021.2249"},{"key":"30449","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1192\/j.eurpsy.2021.2249","DOI":"10.1192\/j.eurpsy.2021.2249"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/3962\/15938","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/3962\/15938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T12:55:48Z","timestamp":1680612948000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/3962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":79,"URL":"https:\/\/doi.org\/10.2340\/actadv.v103.3962","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,4]]}}}